PedAM
Pediatric Disease Annotations & Medicines
| Disease | skin disease |
| Symptom | C0033774|pruritus |
| Sentences | 1 |
| PubMedID- 20687621 | Numerous short- and long-term clinical trials and surveillance studies have shown that twice-daily bepotastine is an effective and generally well tolerated antihistamine in the treatment of patients with allergic rhinitis, chronic urticaria or pruritus associated with skin conditions (eczema/dermatitis, prurigo or pruritus cutaneus). |
Page: 1